Transcarent is a new consumer-directed health and care platform for employees of self-insured employers and their families.

Transcarent's goal is to connect consumers with the right information, resources and tools to help them make the best medical and financial decisions for themselves and their families in a simplified, seamless experience.

Transcarent was founded in 2020 and is headquartered in San Francisco, California.

Transcarent delivers a personalized, 24/7 care experience, addressing virtually all of the most common and most challenging issues a person faces by connecting them with a personal Health Guide or physician.

Transcarent uses a combination of software, technology, data science and health guides to empower consumers with the kind of unbiased information, trusted guidance and access to high-value care that leads to better care, better outcomes, and more cost-effective decisions and allows Members to share in the benefits of their decisions.

Transcarent is backed by General Catalyst, Kinnevik, Merck Global Health Innovation Fund, Kleiner Perkins, Leaps by Bayer, Human Capital, Ally Bridge Group, 7wireVentures, Alta Partners, and others. The company raised $200M in Series C round on Jan 11, 2022. This brings Transcarent's total funding to $298M to date. The latest round mints Transcarent a unicorn with a valuation of $1.62B post-money.